Kyber Network plunges around 23% in just one day as volume spikes on KyberSwap upgrades and new liquidity amalgamations.  Kyber Network Crystal (KNC) accumulatedKyber Network plunges around 23% in just one day as volume spikes on KyberSwap upgrades and new liquidity amalgamations.  Kyber Network Crystal (KNC) accumulated

Kyber Network Jumps 23% as Volume Surges on Upgrades

2026/03/02 20:10
2 min read
For feedback or concerns regarding this content, please contact us at [email protected]
  • The platform also rolled out Smart Exit, aimed at liquidity providers, which automates position exits as per predefined conditions.
  • One more amalgamation is set for future deployment, which is anticipated to further widen the platform’s liquidity access, the company mentioned.

Kyber Network plunges around 23% in just one day as volume spikes on KyberSwap upgrades and new liquidity amalgamations. 

Kyber Network Crystal (KNC) accumulated over 23% in the latest trading sessions, influenced by surged trading volume and the latest platform upgrades, as per the market data. 

The progress of the token compared with losses listed by various large-cap cryptocurrencies in that same period, as per the trading data. Trading volume for Kyber Network Crystal surged substantially in the short term, attaining levels not witnessed in the past few months, as per the exchange data. 

Increased trading volume can boost price movements when amalgamated with purchasing pressure, as per the market analysts. Kyber Network publicised various product amplifications to its decentralised exchange platform. 

The protocol widened cross-chain functionality on its swap product, permitting users to exchange assets over various blockchains using liquidity from different providers in a single transaction, as per the statement of the company. 

The Additional Features 

The platform also rolled out Smart Exit, aimed at liquidity providers, which automates position exits as per predefined conditions for profit-taking, risk management, or time-based parameters, as per the announcement. 

The feature has been placed on some networks, with additional amalgamations planned, the company mentioned. Kyber Network fulfilled an amalgamation with Vaultedge, taking extra assets to the swap platform and widening liquidity routing options, as per the company. 

One more amalgamation is set for future deployment, which is anticipated to further widen the platform’s liquidity access, the company mentioned. Taking the technical analysis perspective into account, the token broke above a short-term moving average that had so far acted as resistance, the chart data reports. 

The level now indicates a potential support zone, technical analysts mention. Keeping price levels over the support could show a continued upward trajectory toward nearby resistance levels. 

A break over resistance may result in extra gains; however, if it does not succeed in holding support, mainly with slipping volume, it could lead to price retracements, as per technical analysis. 

Highlighted Crypto News Today: 

Michael Saylor Signals New Bitcoin Buy Amid Market Weakness

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09